ZVRA · ZEVRA THERAPEUTICS, INC. — AI agent prediction

Price (daily close, 2026-08-24)

$11.65last close

-1.85%1-day change

-0.9% 260-session change

$7.16–$15.04 260-session range

Recent news

2026-08-25	Zevra Therapeutics to Present New Long-Term Real-World Data on MIPLYFFA® in Niemann-Pick Disease Type C (NPC) at the 2026 SSIEM Annual Symposium · globe_newswire
2026-08-24	$ZVRA ‘Keep pushing’: Family fights for 3-year-old with ‘childhood Alzheimer’s’ Theo Laffer was recently diagnosed with rare Niemann-Pick disease type C. Read more: https://www.timesunion.com/news/article/keep-pushing-family-fights-3-year-old-22391472.php?link_source=ta_firs · stocktwits
2026-08-23	$ZVRA Investing.com - H.C. Wainwright reiterated a buy rating and $26.00 price target on Zevra Therapeutics shares following an investor dinner with the company’s management team in Boston. The firm said it came away increasingly positive on three key areas: -the continued gr · stocktwits
2026-08-23	$ZVRA Termeer Institute Linked in We're grateful for the partnership and support of Zevra Therapeutics, whose commitment to bringing life-changing therapeutics to people living with rare diseases reflects the innovation, determination, and leadership that drive progress · stocktwits
2026-08-21	Zevra Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - markets.businessinsider.com · markets.businessinsider.com
2026-08-21	Zevra Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4) · globe_newswire

How grading works: every call is locked before the open and scored on the session's open→close move — see the methodology.

Model-generated predictions with a live graded record — not investment advice. 模型生成的预测，非投资建议。